Revenue | ₹713.31Cr |
Net Profits | ₹93.84Cr |
Net Profit Margins | 13.16% |
ERIS Lifesciences Ltd’s revenue jumped 26.01% since last year same period to ₹713.31Cr in the Q4 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -2.51% fall in its revenue since last 3-months.
ERIS Lifesciences Ltd’s net profit jumped 32.11% since last year same period to ₹93.84Cr in the Q4 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 12.03% jump in its net profits since last 3-months.
ERIS Lifesciences Ltd’s net profit margin jumped 4.84% since last year same period to 13.16% in the Q4 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 14.92% jumped in its net profit margins since last 3-months.
The revenue for ERIS Lifesciences Ltd in the Q4 results 2024 was ₹713.31Cr.
The net profit for ERIS Lifesciences Ltd in the Q4 results 2024 was ₹93.84Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q4 results 2024 was 13.16%.
The revenue for ERIS Lifesciences Ltd in the Q4 results 2023 was ₹566.08Cr.
The net profit for ERIS Lifesciences Ltd in the Q4 results 2023 was ₹71.03Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q4 results 2023 was 12.55%.